Hotline: 1800 102 2007
Hotline: 1800 102 2007
Mar, 22 2019

J&J enters into agreement with Monash University to advance novel technology

The agreement has been signed between both of them to advance the development of an inhaled version of oxytocin in order to help prevent and manage Post-Partum Hemorrhage (PPH).

J&J enters into agreement with Monash University to advance novel technology

Janssen Pharmaceutica N.V, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has signed a sponsored research agreement with the Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University.

The agreement has been signed between both of them to advance the development of an inhaled version of oxytocin in order to help prevent and manage Post-Partum Hemorrhage (PPH).

Jaak Peeters, Global Head, Johnson & Johnson Global Public Health, Janssen-Cilag GmBH, said, “When you consider the lifetime risk of dying for a woman in childbirth is 23 times higher in resource-limited settings than anywhere else you must act if you have the scientific capabilities to potentially help overcome that inequity. We hope to address this significant unmet need by helping accelerate the development of what would be a truly life-saving innovation and give women and their families everywhere the same chance at life.”

Michelle McIntosh, Monash Institute of Pharmaceutical Sciences, Monash University, added, “This is an exciting opportunity to expand this collaboration between industry and academia to develop an important healthcare innovation that aims to address a critical unmet medical need. There is a massive ripple effect when a mother dies – it's a very significant burden for these families and communities, and we are committed to bringing the gold-standard care to all mothers.”

Kathy Connell, Senior Director, New Ventures, Australia & New Zealand, Johnson & Johnson Innovation, further stated, “This latest agreement between Johnson & Johnson and Monash University, an internationally renowned leader in pharmacy and pharmacology, builds on our legacy of innovative academic-industry collaborations in Australia focused on developing life-saving treatments for the highest unmet needs.”

sharebtn
Comment
user
email
mobile
address
star
Related opportunities
  • About Us: Living Healthy 24, a venture of Kolkata-based Culmination Healthcare..
    Locations looking for expansion West bengal
    Establishment year 2016
    Franchising Launch Date 2019
    Investment size Rs. 20lac - 30lac
    Space required 200
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater kolkata West bengal
  • Tea And Coffee Chain
    About Us: Ritazza is an international chain of coffee shops specialising in..
    Locations looking for expansion Delhi
    Establishment year 1988
    Franchising Launch Date 1955
    Investment size Rs. 1 Cr. - 2 Cr
    Space required -NA-
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater New delhi Delhi
  • Automotive Parts And Components
    About Us: Luman Group is an IATF 16949:2016 certified OEM manufacturer..
    Locations looking for expansion Uttarakhand
    Establishment year 1978
    Franchising Launch Date 2010
    Investment size
    Space required 250
    Franchise Outlets -NA-
    Franchise Type -NA-
    Headquater Pantnagar Uttarakhand
  • Fine Dine Restaurants
    About Us: Located in Andheri, The newest eatery to make its way..
    Locations looking for expansion Maharashtra
    Establishment year 2017
    Franchising Launch Date 2018
    Investment size Rs. 1 Cr. - 2 Cr
    Space required 2000
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Mumbai Maharashtra
Insta-Subscribe to
Entrepreneur
Magazine
sme-80x109
For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you
email
mobile
OR Click here to Subscribe Online
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities